Beijing Science Sun Pharmaceutical Co.,Ltd.’s Net Profit Rose 7.3% in First Half of 2023

Beijing Science Sun Pharmaceutical Co.,Ltd. (北京赛升药业股份有限公司) (300485.SZ) reported a net profit of 249.5 million yuan in the first half of 2023, up 7.3% year-on-year.

Meanwhile, the company posted 272 million yuan in revenue, down 29% year-on-year.

At the end of the reporting period, it had 3.8 billion yuan in total assets and 156 million yuan in total liabilities, with a liability-to-asset ratio of 4.1%.